Bristol-Myers to Acquire Celgene in Deal Worth $74 Billion

Together, the merged companies would have nine pharmaceutical products with more than $1 billion in annual sales. The deal is expected to be completed in the third quarter.

from NYT > Health https://nyti.ms/2Tq60SG
via health&fitness